Description
Preliminary Programme
Access the Scientific Brochure now for full programme details — including accreditations, session highlights led by renowned international faculty, endorsements from leading scientific societies, profiles of the scientific organisers, venue information and much more!
Overview
Advancing Diagnosis and Treatment in Myasthenia Gravis
The diagnostic and therapeutic landscape of Myasthenia Gravis (MG) is evolving rapidly—with new antibody assays and emerging treatment options improving outcomes, yet adding complexity to clinical decision-making.
Effective management of MG increasingly relies on multidisciplinary collaboration, spanning neurology, immunology, surgery, and beyond.
The upcoming International Workshop on Myasthenia Gravis offers a timely platform for experts to connect, share insights, and navigate these developments together.
Access the Scientific Programme for more details and Register for this limited availability, FREE event.
Call for Abstracts
We invite submissions of abstracts that address topics and issues involving antibody-mediated neurological diseases.
We encourage you to SUBMIT YOUR WORK HERE . The deadline for abstract submissions has now been extended to 6th October, 2025.
A limited number of abstracts could be selected and will be presented during the Workshop.
For any additional questions or queries please contact Maria Sole Capitani